News search

E.g., 01/10/2022
E.g., 01/10/2022
About the CNIC
19 Sep 2022

CNIC's leader have been recognized for his exceptional career achievements at the 34th annual conference

Fernando de Frutos y el Dr. Pablo García Pavía.
Research
29 Aug 2022

The findings, published in the Journal of the American College of Cardiology (JACC), represent a first step towards the personalized treatment of patients with this disease

Valentín Fuster
Research
26 Aug 2022

The results of the SECURE trial, coordinated by CNIC were presented in a Hot Line session at the European Society of Cardiology meeting (ESC 2022) in Barcelona and published at the NEJM

La Dra. Amelia Escolano
About the CNIC
9 Aug 2022

Dr. Amelia Escolano runs her own group in Philadelphia (USA) where she is an Assistant Professor at the Wistar Institute's Center for Vaccines and Immunotherapy

Participants who followed the TANSNIP-PESA program (orange line) showed an improvement in lifestyle measures and cardiovascular health compared with participants in the control group (who did not participate in the intervention; blue line). The Y-axis shows changes in the Fuster -BEWAT lifestyle and cardiovascular risk score with respect to the baseline value.
Research
26 Jul 2022

Adherence to a workplace cardiovascular health-promotion program improves lifestyle and risk factors in healthy individuals

Andrés Hidalgo
About the CNIC
6 Jul 2022

Through this lifelong honour, new EMBO Members and Associate Members are recognized for their outstanding achievements in the life sciences

Juan Domingo Gisbert
About the CNIC
24 Jun 2022

Juan Domingo Gispert López, head of the Barcelonaβeta Brain Research Center and CNIC (Spanish National Centre for Cardiovascular Research) researcher


Dr. Cristóbal Belda se convirtió en el nuevo Director del Instituto de Salud Carlos III.
Valentín Fuster
About the CNIC
4 Apr 2022

CNIC leader will be recognized for his exceptional achievements at the 71st annual conference


José Javier Fuster
About the CNIC
23 Feb 2022

Researchers from the CNIC and Columbia University (USA) review the role of acquired mutations and clonal hematopoiesis in cardiovascular disease